BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.47B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.89B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$708M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$524M |
| 5 |
Nike
NKE
|
+$468M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$293M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$74.9M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$72.9M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Financials | 8.36% |
| 4 | Healthcare | 7.6% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Comp X International
CIX
$282M
| $6.7K | ﹤0.01% |
285
-620
| -69% | -$14.6K |
|
3077
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.35B
| $6.66K | ﹤0.01% |
135
-21,137
| -99% | -$1.04M |
|
|
EDN
3078
Edenor
EDN
$822M
| $6.55K | ﹤0.01% |
+971
| New | +$6.55K |
|
|
ATNX
3079
DELISTED
Athenex, Inc. Common Stock
ATNX
| $6.54K | ﹤0.01% |
394
-769
| -66% | -$12.8K |
|
3080
MEI Pharma
MEIP
$101M
| $6.5K | ﹤0.01% |
540
-1,070
| -66% | -$12.9K |
|
|
SYRS
3081
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.43K | ﹤0.01% |
540
-735
| -58% | -$8.75K |
|
3082
Priority Technology Holdings
PRTH
$602M
| $6.41K | ﹤0.01% |
1,114
-1,250
| -53% | -$7.19K |
|
|
NTP
3083
DELISTED
Nam Tai Property Inc.
NTP
| $6.14K | ﹤0.01% |
+982
| New | +$6.14K |
|
3084
Santander
BSBR
$40B
| $6.12K | ﹤0.01% |
795
-42,776
| -98% | -$329K |
|
3085
Pulse Biosciences
PLSE
$994M
| $6.03K | ﹤0.01% |
1,241
-1,757
| -59% | -$8.54K |
|
|
CWBC
3086
Community West Bancshares
CWBC
$402M
| $6.02K | ﹤0.01% |
258
+200
| +345% | +$4.67K |
|
3087
iShares MSCI USA Momentum Factor ETF
MTUM
$18.9B
| $5.89K | ﹤0.01% |
35
-5,393
| -99% | -$907K |
|
3088
Value Line
VALU
$359M
| $5.83K | ﹤0.01% |
87
-131
| -60% | -$8.78K |
|
3089
Harrow
HROW
$1.44B
| $5.62K | ﹤0.01% |
824
+402
| +95% | +$2.74K |
|
3090
HSBC
HSBC
$237B
| $5.48K | ﹤0.01% |
160
-25,888
| -99% | -$886K |
|
3091
Arq
ARQ
$298M
| $5.23K | ﹤0.01% |
841
+787
| +1,457% | +$4.9K |
|
3092
Banco Santander Chile
BSAC
$12.2B
| $5.22K | ﹤0.01% |
231
-243
| -51% | -$5.49K |
|
3093
Farmers & Merchants Bancorp
FMAO
$353M
| $5.03K | ﹤0.01% |
139
-40
| -22% | -$1.45K |
|
3094
NACCO Industries
NC
$293M
| $5.02K | ﹤0.01% |
128
-3
| -2% | -$118 |
|
3095
RGC Resources
RGCO
$227M
| $4.91K | ﹤0.01% |
227
-1
| -0.4% | -$22 |
|
3096
ESSA Pharma
EPIX
$9.7M
| $4.9K | ﹤0.01% |
792
+736
| +1,314% | +$4.55K |
|
3097
Hercules Capital
HTGC
$3.51B
| $4.83K | ﹤0.01% |
267
| – | – |
|
|
DRD
3098
DRDGold
DRD
$1.97B
| $4.79K | ﹤0.01% |
511
| – | – |
|
|
HOOK
3099
DELISTED
HOOKIPA Pharma
HOOK
| $4.66K | ﹤0.01% |
204
-249
| -55% | -$5.69K |
|
|
VNE
3100
DELISTED
Veoneer, Inc.
VNE
| $4.66K | ﹤0.01% |
126
-130
| -51% | -$4.8K |
|